跳至主要内容
临床试验/CTRI/2025/06/089711
CTRI/2025/06/089711尚未招募4 期

A Clinical Study On The Utility Of Kent Repertory In The Treatment Of Irritable Bowel Syndrome

RBTS Government Homoeopathic Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年7月8日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
It is expected from the study that it will increase the scope of KENT Homoeopathic repertory in selecting homoeopathic medicines in the treatment of Gastro intestinal disordes especilally in Irritable Bowel Syndrome and will provide a good alternative to the conventional mode of treatment with no side effects. It will also bring statistically more significant changes in the ROME Criteria.

研究概览

简要总结

Irritable Bowel Syndrome is a chronic functional GI disorder characterised by symptoms like recurrent pain in abdomen / dsiscomfort associated with alter bowel habit either contipation or diarrhoea. Patients Get relief from presenting complain when homoeopathic medicine prescribed on the basis of symptoms similarity by using Kent homoeopathic repertory.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • .Patients following ROME IV criteria will be included .Patients of both sexes will be included .Patients of 25-40 years of age will included .Patients of all religion and different socio- economic status will be included .Patients who give consent for Homoeopathic treatment will be included .Patients having no co-morbidity will be included.

排除标准

  • .Patient suffering from any systemic illness will be excluded .Age below 25 years and above 40 Years will be excluded .Patient who do not give consent for Homoeopathic treatment will be excluded .Patient having any pathological abnormality will be excluded .Pregnancy condition will be excluded.

结局指标

主要结局

It is expected from the study that it will increase the scope of KENT Homoeopathic repertory in selecting homoeopathic medicines in the treatment of Gastro intestinal disordes especilally in Irritable Bowel Syndrome and will provide a good alternative to the conventional mode of treatment with no side effects. It will also bring statistically more significant changes in the ROME Criteria.

时间窗: 3-4 MONTHS

次要结局

  • To find out group of homoeopathic medicines effective in managing the cases of Irritable Bowel Syndrome and To see the changes in Patient-Oriented(ROME Criteria)

研究者

发起方
RBTS Government Homoeopathic Medical College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Bhuvan Kumar

RBTS Government Homoeopathic Medical College and HospitalMuzaffarpur, Bihar.

研究点 (1)

Loading locations...

相似试验